A first-in-human study, in HIV-positive men, of the novel HIV-fusion inhibitor C34-PEG4-Chol - Quinn, K; Bouliotis, G; Doyle, N; Winston, A; Ashby, D; Weber, J; Libri, V; Amara, A; Back, D; Penchala, SD; Khoo, S; Nelson, M; et al. (Wiley, 2016)